Sulfadiazine/BSA is an antigen-adjuvant conjugate of Sulfadiazine with bovine serum albumin (BSA). By conjugating antigens with a protein adjuvant, it enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or alter major epitopes and can boost cross-presentation and antigen-specific T cell production.